SOLV
Solventum Corp.
NYSE: SOLV · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$66.49
-1.51% today
Updated 2026-04-29
Market cap
$11.54B
P/E ratio
7.49
P/S ratio
1.39x
EPS (TTM)
$8.88
Dividend yield
—
52W range
$62 – $88
Volume
1.3M
WallStSmart proprietary scores
70
out of 100
Grade: B
Buy
Investment rating
5.3
Growth
C+4.5
Quality
C7.0
Profitability
B+8.7
Valuation
A3/9
Piotroski F-Score
Weak
1.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$84.18
+26.61%
12-Month target
$64.67
-2.74%
Intrinsic (DCF)
$205.96
Margin of safety
+60.43%
1 Strong Buy5 Buy6 Hold2 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 38.90% — strong efficiency
+ Free cash flow $32.00M — positive
+ 60.43% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 1.27 — distress zone
- Revenue declining -3.70% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $8.13B | $8.20B | $8.25B | $8.32B | $8.32B |
| Net income | $1.34B | $1.35B | $479.00M | $1.56B | $63.00M |
| EPS | — | — | — | — | $8.88 |
| Free cash flow | $1.43B | $1.63B | $805.00M | $-10.00M | $32.00M |
| Profit margin | 16.52% | 16.42% | 5.80% | 18.69% | 18.70% |
Peer comparison
Smart narrative
Solventum Corp. trades at $66.49. representing a P/E of 7.49x trailing earnings. Our Smart Value Score of 70/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 1.27, it sits in the distress. TTM revenue stands at $8.32B. with profit margins at 18.70%. Our DCF model estimates intrinsic value at $205.96.
Frequently asked questions
What is Solventum Corp.'s stock price?
Solventum Corp. (SOLV) trades at $66.49.
Is Solventum Corp. overvalued?
Smart Value Score 70/100 (Grade B, Buy). DCF value $205.96.
What is the price target of Solventum Corp. (SOLV)?
The analyst target price is $84.18, representing +26.6% upside from the current price of $66.49.
What is the intrinsic value of Solventum Corp. (SOLV)?
Based on our DCF model, intrinsic value is $205.96, a +60.4% margin of safety versus $66.49.
What is Solventum Corp.'s revenue?
TTM revenue is $8.32B.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
1.27 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.39x
ROE38.90%
Beta0.77
50D MA$68.33
200D MA$73.93
Shares out0.17B
Float0.15B
Short ratio—
Avg volume1.3M
Performance
1 week-2.96%
1 month+3.33%
3 months-13.62%
YTD-16.09%
1 year—
3 years—
5 years—